253 related articles for article (PubMed ID: 16266370)
1. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
4. A mutation of ion-conducting pore without effect on ion selectivity of the sodium channel.
Vornanen M
Acta Physiol Scand; 2005 Dec; 185(4):257. PubMed ID: 16266366
[No Abstract] [Full Text] [Related]
5. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
Wang DW; Makita N; Kitabatake A; Balser JR; George AL
Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
[TBL] [Abstract][Full Text] [Related]
7. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
[TBL] [Abstract][Full Text] [Related]
8. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
Itoh H; Shimizu M; Mabuchi H; Imoto K
J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V.
Mohammadi B; Mitrovic N; Lehmann-Horn F; Dengler R; Bufler J
J Physiol; 2003 Mar; 547(Pt 3):691-8. PubMed ID: 12562902
[TBL] [Abstract][Full Text] [Related]
10. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs.
Itoh H; Shimizu M; Takata S; Mabuchi H; Imoto K
J Cardiovasc Electrophysiol; 2005 May; 16(5):486-93. PubMed ID: 15877619
[TBL] [Abstract][Full Text] [Related]
11. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
[TBL] [Abstract][Full Text] [Related]
12. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.
Baroudi G; Acharfi S; Larouche C; Chahine M
Circ Res; 2002 Jan; 90(1):E11-6. PubMed ID: 11786529
[TBL] [Abstract][Full Text] [Related]
13. The genetic basis of Brugada syndrome: a mutation update.
Hedley PL; Jørgensen P; Schlamowitz S; Moolman-Smook J; Kanters JK; Corfield VA; Christiansen M
Hum Mutat; 2009 Sep; 30(9):1256-66. PubMed ID: 19606473
[TBL] [Abstract][Full Text] [Related]
14. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.
Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW
Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786
[TBL] [Abstract][Full Text] [Related]
16. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
[TBL] [Abstract][Full Text] [Related]
17. Mutation-specific effects of lidocaine in Brugada syndrome.
Clancy CE; Wehrens XH
Int J Cardiol; 2007 Oct; 121(3):249-52. PubMed ID: 17761312
[TBL] [Abstract][Full Text] [Related]
18. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
[TBL] [Abstract][Full Text] [Related]
19. Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis.
Carle T; Lhuillier L; Luce S; Sternberg D; Devuyst O; Fontaine B; Tabti N
Biochem Biophys Res Commun; 2006 Sep; 348(2):653-61. PubMed ID: 16890191
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase.
Lee HC; Patel MK; Mistry DJ; Wang Q; Reddy S; Moorman JR; Mounsey JP
Physiol Genomics; 2003 Jan; 12(2):147-57. PubMed ID: 12454205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
